Ra Capital Management, L.P.insider trades
In SEC Form 4 filings, Ra Capital Management, L.P. is listed as Director, 10% owner of Wave Life Sciences, Inc. (WVE), 10% owner of Vor Biopharma Inc. (VOR), Director, 10% owner of Climb Bio, Inc. (CLYM) and 3 other companies. In the last 90 days, Ra Capital Management, L.P. sold $21.84M of Sionna Therapeutics, Inc. (SION) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| WVEWave Life Sciences, Inc. | Director, 10% owner | 2 | Oct 7 |
| VORVor Biopharma Inc. | 10% owner | 4 | Oct 5 |
| CLYMClimb Bio, Inc. | Director, 10% owner | 8 | Sep 30 |
| SIONSionna Therapeutics, Inc. | Director, 10% owner | 2 | Sep 21 |
| TYRATyra Biosciences, Inc. | Director, 10% owner | 1 | Sep 17 |
| ARTVArtiva Biotherapeutics, Inc. | Director, 10% owner | 2 | Sep 14 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-26
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| WVEWave Life Sciences, Inc. | Oct 5 | Oct 7 | A | 10,700 | $0.00 | $0 | 39,515 | No | Form 4 |
| WVEWave Life Sciences, Inc. | Oct 5 | Oct 7 | A · derivative | 64,000 | $3.75 | $240,000 | 64,000 | No | Form 4 |
| VORVor Biopharma Inc. | Oct 2 | Oct 5 | M | 500 | $12.80 | $6,400 | 500 | No | Form 4 |
| VORVor Biopharma Inc. | Oct 2 | Oct 5 | M · derivative | 500 | $12.80 | $6,400 | not reported | No | Form 4 |
| CLYMClimb Bio, Inc. | Sep 28 | Sep 30 | M | 10,000 | $3.46 | $34,600 | 10,000 | No | Form 4 |
| CLYMClimb Bio, Inc. | Sep 28 | Sep 30 | M | 10,000 | $3.00 | $30,000 | 20,000 | No | Form 4 |
| CLYMClimb Bio, Inc. | Sep 28 | Sep 30 | M | 10,000 | $7.89 | $78,900 | 30,000 | No | Form 4 |
| CLYMClimb Bio, Inc. | Sep 28 | Sep 30 | M | 40,000 | $1.29 | $51,600 | 70,000 | No | Form 4 |
| CLYMClimb Bio, Inc. | Sep 28 | Sep 30 | M · derivative | 10,000 | $3.46 | $34,600 | not reported | No | Form 4 |
| CLYMClimb Bio, Inc. | Sep 28 | Sep 30 | M · derivative | 10,000 | $3.00 | $30,000 | not reported | No | Form 4 |
| CLYMClimb Bio, Inc. | Sep 28 | Sep 30 | M · derivative | 10,000 | $7.89 | $78,900 | not reported | No | Form 4 |
| CLYMClimb Bio, Inc. | Sep 28 | Sep 30 | M · derivative | 40,000 | $1.29 | $51,600 | not reported | No | Form 4 |
| SIONSionna Therapeutics, Inc. | Sep 17 | Sep 21 | S | 3,415,011 | $6.32 | Sale −$21,582,870 | 3,482,612 | No | Form 4 |
| SIONSionna Therapeutics, Inc. | Sep 17 | Sep 21 | S | 33,800 | $7.46 | Sale −$252,148 | 3,448,812 | No | Form 4 |
| TYRATyra Biosciences, Inc. | Sep 15 | Sep 17 | P · derivative | 9,078,529 | $22.03 | Purchase +$199,990,915 | 11,616,986 | No | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Sep 10 | Sep 14 | A · derivative | 16,250 | $10.42 | $169,325 | 16,250 | No | Form 4 |
| ARTVArtiva Biotherapeutics, Inc. | Sep 8 | Sep 8 | A · derivative | 13,750 | $10.88 | $149,600 | 13,750 | No | Form 4 |
| VORVor Biopharma Inc. | Aug 24 | Aug 26 | M | 1,500 | $3.74 | $5,604 | 1,500 | No | Form 4 |
| VORVor Biopharma Inc. | Aug 24 | Aug 26 | M · derivative | 1,500 | $3.74 | $5,604 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.